They concluded that the estrogen upregulates hTERT gene expression and telomerase activity in several estrogen receptor (ER) of positive cancer cell lines, while androgen increased this activity in prostate cancer cells but reduced it in normal prostate. The gene discussed is ESR1; the disease is prostate carcinoma.